Clinical Trials Browser

Interventional × Hypersensitivity × Myeloid × Clear all

NCT05186753 2026-05-22

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

Hematologic Diseases, Hypersensitivity, Immune Complex Diseases, Immune System Diseases, Mastocytosis, Mastocytosis, Systemic

NCT04996875 2026-05-05

APEX

Phase 2 Recruiting

140 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Hypersensitivity, Immune Complex Diseases, Immune System Diseases, Leukemia, Leukemia, Mast-Cell, Leukemia, Myeloid, Mastocytosis, Myeloproliferative Disorders, Neoplasms, Neoplasms by Site, Neoplasms, Connective Tissue, Skin Diseases, Soft Tissue Neoplasms, Urticaria Pigmentosa, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Mastocytosis, Systemic

NCT04761822 2025-08-12

SARS

Phase 2 Completed

746 enrolled 28 charts

Myeloid

COVID-19, Hypersensitivity, Mastocytosis, Severe Acute Respiratory Syndrome

NCT05001386 2022-03-17

ESAAC

Phase NA Unknown

800 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hypersensitivity, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Hematologic Neoplasms